CSIMarket
 
Constellation Pharmaceuticals Inc  (CNST)
Other Ticker:  
 
 

Constellation Pharmaceuticals Inc Income Statement Quarterly

CNST


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Revenue From Contract With Customer Excluding Assessed Tax - - - -
Total Revenue 0.00 0.00 0.00 0.00 0.00
Cost of Revenues - - - - -
Gross Profit 0.00 0.00 0.00 0.00 0.00
Selling, Administration, Marketing 9.44 8.54 7.94 6.96 5.91
Gain (Loss) on Disposition of Property Plant Equipment - 0.01 - 0.03 -
Depriciation & Amortization - - - - -
Research and Development Expense 30.78 27.36 25.44 22.63 20.08
Restructuring, Accretion & impairment charges - - - - -
Other operatinig exp. /-income - -0.01 - -0.03 -
Unusual Expense /-Income - - - - -
Total operating costs including COS 40.23 35.90 33.38 29.59 25.98
Operating income/-loss -40.23 -35.90 -33.38 -29.59 -25.98
Other Deductions / - Income
Interest expense - 0.30 0.86 0.86 0.85
Interest income - - - - -
Net interest expense/-income - 0.30 0.86 0.86 0.85
Extinguishment of Debt - 1.50 - - -
Investment Income, Interest -0.15 -0.30 -0.46 -0.69 -1.40
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income 0.00 -0.01 0.00 -0.03 0.00
Total costs & expenses 40.07 37.38 33.78 29.73 25.43
Income /-loss before income taxes -40.07 -37.38 -33.78 -29.73 -25.43
Income taxes expenses/-benefit - - - 0.02 0.02
Income after income taxes -40.07 -37.38 -33.78 -29.75 -25.44
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. -40.07 -37.38 -33.78 -29.75 -25.44
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss -40.07 -37.38 -33.78 -29.75 -25.44
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -40.07 -37.38 -33.78 -29.75 -25.44
EBIT -40.07 -37.09 -32.92 -28.87 -24.58
EBITD -39.87 -36.88 -32.75 -28.75 -24.43
EBITDA -39.87 -36.88 -32.75 -28.75 -24.43


Per Share (GAAP Quarterly, in $) (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Basic EPS (excl. extra items) -0.84 -0.78 -0.71 -0.70 -0.61
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -0.84 -0.78 -0.71 -0.70 -0.61
Basic shares outstanding (Mill. of Units) 47.84 47.67 47.53 42.59 41.77
   EPS other shares - - - - -
Diluted Net EPS -0.84 -0.78 -0.71 -0.70 -0.61
Diluted average shares (Mill. of Units) 47.84 47.67 47.53 42.59 41.77
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com